Results 121 to 130 of about 134,715 (210)

Acetylsalicylic acid versus clopidogrel in cardiovascular prevention: Does the classic still outperform the contemporary? [PDF]

EXCLI J
Sousa IJO, de Melo Nogueira K.
europepmc   +1 more source

Outcomes and risk factors of hemorrhage in patients with resected brain metastases

International Journal of Cancer, Volume 158, Issue 8, Page 2120-2138, 15 April 2026.
What's New? Brain metastases may present with hemorrhage, yet risk factors and clinical outcomes remain unclear. Based on a cohort of 880 patients with resected brain metastases, this study identified tumor volume and primary tumor histology (melanoma and non‐small cell lung cancer) as key predictors of hemorrhage.
Melisa S. Guelen, Kiarash Ferdowssian, Niklas Jung, Hava N. Celik, Andrea Dell'Orco, Semil Eminovic, Anton Früh, Majd Samman, Güliz Acker, Arend Koch, Helena Radbruch, Michael Scheel, Mike P. Wattjes, Julia Onken, Peter Vajkoczy, Nils Hecht, Jawed Nawabi, David Wasilewski   +17 more
wiley   +1 more source

Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes. [PDF]

Acta Neurochir (Wien)
Li C, Yuan H, Duan C, Feng X, Liu W, Huang J, Huang C, Huang M, Wen Z, Ge R, Lin J, Jin F, Li R, Guo S, Chen C, Liang S, Li X.   +16 more
europepmc   +1 more source

Clopidogrel Dosing Scheme in Pediatric Cardiac Patients 0-24 Months Old Using P2Y₁₂ Reaction Unit Monitoring. [PDF]

J Pediatr Pharmacol Ther
Anton-Martin P, Coalter C, DeAvilla K, Ray M, W Kozyak B, Briceno-Medina M, Rayburn M.   +6 more
europepmc   +1 more source

Clinical outcomes of a generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: a nationwide retrospective cohort study. [PDF]

BMC Neurol
Chen CJ, Hung CH, Hsiao FC, Lin CP, Hsu TJ, Chu PH.   +5 more
europepmc   +1 more source

Overcoming Clopidogrel Resistance in Carotid Artery Stenting: Experience with Ticagrelor and Ticlopidine. [PDF]

Clin Pract
Vigláš P, Raupach J, Hejčl A, Černík D, Bradáčová P, Matras P, Cihlář F.   +6 more
europepmc   +1 more source

Clopidogrel use is associated with an increased prevalence of Parkinson's disease, particularly among US adults with diabetes. [PDF]

Clin Park Relat Disord
Zhan J, Zhang W, Liu Y, Guan S, Lin X, Yang J, Yuan W, Zhou L, Huang G.   +8 more
europepmc   +1 more source

Efficacy and safety of clopidogrel and aspirin in patients with chronic coronary syndrome: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Wei X, Yang Z, Chen M, Lu H, Hou S.
europepmc   +1 more source

Rebound Phenomenon of Platelet Reactivity After Cessation of Long-Term Clopidogrel Therapy. [PDF]

JACC Asia
Han JK, Lee H, Hwang D, Kang J, Yang HM, Park KW, Kang HJ, Koo BK.   +7 more
europepmc   +1 more source

Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON‐CABG CardioLink‐5 trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4376-4381, May 2026.
Hwee Teoh, Subodh Verma, G. B. John Mancini, Adrian Quan, Michael Szarek, Randi Elituv, Meena Verma, Elizabeth Misner, Aishwarya Krishnaraj, Peter Jüni, Michael J. Koren, Stephen J. Nicholls, Deepak L. Bhatt, C. David Mazer, Lawrence A. Leiter   +14 more
wiley   +1 more source